Volitionrx (VNRX) Revenue (QoQ) (2012 - 2025)
Volitionrx (VNRX) Revenue (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn |
| 10 | Volitionrx | 90,883.07 | -1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42.23% |
| Sep 30, 2025 | 156.13% |
| Jun 30, 2025 | -0.60% |
| Mar 31, 2025 | 106.64% |
| Dec 31, 2024 | -70.64% |
| Sep 30, 2024 | 45.18% |
| Jun 30, 2024 | 65.90% |
| Mar 31, 2024 | 151.16% |
| Dec 31, 2023 | -47.36% |
| Sep 30, 2023 | -41.05% |
| Jun 30, 2023 | 49.75% |
| Mar 31, 2023 | 243.48% |
| Dec 31, 2022 | -605.34% |
| Sep 30, 2022 | -49.88% |
| Jun 30, 2022 | -65.19% |
| Mar 31, 2022 | 702.04% |
| Dec 31, 2021 | -44.12% |
| Sep 30, 2021 | 2.83% |
| Jun 30, 2021 | -2.93% |
| Mar 31, 2021 | 258.57% |